Investing in GSK
GSK is currently the largest healthcare company in the UK with offices in more than 100 countries and major research centres in the UK, USA, Belgium and China. In recent years, GSK has focused its business around three strategic priorities which aim to increase growth, reduce risk and improve long-term financial performance.
We are succeeding in our strategy to create a more balanced business capable of addressing the market challenges we face, delivering sustainable financial performance and providing new value to patients and consumers. In 2011, we delivered underlying sales growth, strong cash generation, significant R&D progress and increased shareholder returns.
We are committed to using free cash flow to support increasing dividends, share repurchases or, where returns are more attractive, bolt-on acquisitions.
Discover more...
Our businesses
Find out about our three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare, and also about the value we place on R&D.
Our performance
Find out about our sales performance, shareholder returns and productivity.
Financial architecture
Information on our new financial architecture which we established in 2011.